Gene · 9589
Papers3,474
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,474
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative analysis of the m6A epitranscriptome in HeLa-expressed HPV18 early transcripts reveals its potential impact on splicing. | RNA | 2026 | 42303463 | PubTator, text mining | PubMed |
| WTAP-mediated m6A methylation of CEP55 promotes immune evasion in lung adenocarcinoma by activating the PI3K/AKT/mTOR pathway. | Mol Genet Genomics | 2026 | 42298019 | PubTator, text mining | PubMed |
| HILPDA, Regulated by WTAP in an m6A-Dependent Manner, Enhances Osteosarcoma Development by Inhibiting Ferroptosis and Promoting Glycolysis. | Biochem Genet | 2026 | 42274843 | PubTator, text mining | PubMed |
| Landscape of N6-methyladenosine (m6A) methylation in porcine cells identifies candidate genes associated with porcine epidemic diarrhea virus infection. | Front Microbiol | 2026 | 42232905 | PubTator, text mining | PubMed |
| WTAP tetramer ensures m6A writer assembly and faithful mitosis. | EMBO Rep | 2026 | 42231024 | PubTator, text mining | PubMed |
| Immunometabolic reprogramming in rheumatoid arthritis: the epitranscriptomic role of N6-methyladenosine in innate and adaptive immunity. | Front Immunol | 2026 | 42212124 | PubTator, text mining | PubMed |
| Icariin suppresses glycolysis in prostate cancer by upregulating ALKBH5 to mediate EARS2 m6A demethylation. | J Mol Histol | 2026 | 42185511 | PubTator, text mining | PubMed |
| m6A modification-mediated lncRNA UNC5B-AS1 enhances HCC progression through miR-760/IL6 axis. | Sci Rep | 2026 | 42178363 | PubTator, text mining | PubMed |
| Correction: Genetic Evidence Supports a Potential Role of WTAP-related m6A Regulation in Vascular Dementia: Insights from Mendelian Randomization and Multi-omics Analyses. | J Mol Neurosci | 2026 | 42162351 | PubTator, text mining | PubMed |
| WTAP -mediated N6‑methylation of TRAF6 Facilitates Polycystic Ovary Syndrome by Inducing Ferroptosis. | Reprod Sci | 2026 | 42115577 | PubTator, text mining | PubMed |
| METTL3-Mediated m6A Modification Promotes the Stability of PLCζ mRNA in Sperm. | Mol Reprod Dev | 2026 | 42112538 | PubTator, text mining | PubMed |
| WTAP-Mediated m6A Modification Targets the LRP1-Lipid Metabolism Axis to Regulate Joint Cartilage Regeneration. | Adv Sci (Weinh) | 2026 | 42089425 | PubTator, text mining | PubMed |
| Emerging roles of m6A modification in endodontic diseases: a systematic review. | Epigenomics | 2026 | 42080597 | PubTator, text mining | PubMed |
| WTAP stabilized by USP7 contributes to enzalutamide resistance in prostate cancer via mediating AKT m6A-modification. | Cancer Gene Ther | 2026 | 41981278 | PubTator, text mining | PubMed |
| WTAP-Driven m6A Modification of TIMP1 mRNA Promotes Sepsis-Induced Cardiomyocytes Injury. | Biochem Genet | 2026 | 41973152 | PubTator, text mining | PubMed |
| m6A RNA methylation regulatory gene expression in response to ethanol and acetaldehyde exposure and withdrawal. | Environ Epigenet | 2026 | 41970606 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| WTAP stabilizes MMP12 expression to promote the malignant phenotypes of esophageal cancer cells. | Regen Ther | 2026 | 41909913 | PubTator, text mining | PubMed |
| Study on the mechanism of action of HuaZhuoKeLi in modulating LCN2-mediated cellular pyroptosis to ameliorate ulcerative colitis. | Sci Rep | 2026 | 41904244 | PubTator, text mining | PubMed |
| ENDOU-1-induced cytoplasmic HnRNPA3 recognizes m6A methylation on the upstream reading frame of human CHOP transcripts to achieve maximal CHOP translation. | Cell Mol Life Sci | 2026 | 41902934 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9589/papers?page=2